Kirby mcinerney llp reminds revance therapeutics, inc. (rvnc) investors of class action filing and encourages investors to contact the firm

New york, jan. 10, 2025 (globe newswire) -- the law firm of kirby mcinerney llp reminds investors who purchased revance therapeutics, inc. (“revance” or the “company”) (nasdaq:rvnc) securities to contact thomas w. elrod of kirby mcinerney llp by email at investigations@kmllp.com, or fill out the contact form below, to discuss your rights or interests with respect to the securities fraud class action lawsuit against the company.
RVNC Ratings Summary
RVNC Quant Ranking